Business
CAP accreditation
CAP accreditation.
About this update from Hvivo Plc
[{"type":"text","content":"\n \n \n \n Open Orphan plc\n \n \n \n \n (\"Open Orphan\" or the \"Company\")\n \n \n \n \n \n \n \n Clinical laboratories achieves CAP accreditation\n \n \n \n \n \n \n \n Confirms hVIVO laboratories high standard of excellence\n \n \n \n \n \n \n \n Open Orphan plc\n \n (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that its clinical laboratories in Queen Mary's Bioenterprise Centre and Plumbers Row (hLab) have been awarded accreditation by the College of American Pathologists (\"CAP\"). The Company sought the accreditation as part of its ongoing commitment to maintaining best in class quality systems.\n \n \n \n \n \n The CAP is the world's largest organisation of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programmes. The accreditation \"supports laboratories performing testing on specimens from human, using methodologies and clinical application within the expertise of the program\". This further expands on the Company's Good Clinical Practice for Laboratories (GCLP) accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA) and provides additional quality assurances of its laboratory services for its clients, especially within the United States, thus ensuring the accuracy of test results and conforming to the requirements from the US Food and Drug Administration (FDA).\n \n \n \n \n \n \n hLab\n \n is a highly specialised virology and immunology laboratory, offering a suite of services to support both pre-clinical and clinical respiratory drug and vaccine discovery and development. This includes assay development, transfer and optimisation across immunology, molecular and cell-based assays, including extensive options in sample matrix and stability testing and analysis. hLab is well equipped with Biosafety Level 2 and 3 facilities to provide high quality data outputs to enable clients to achieve early proof of concept, or to make a breakthrough discovery in the pathology and possible treatment of diseases with unmet medical needs. hLAB now provides services beyond supporting the Company's in-house human challenge trials, offering lab services as a standalone serv...